Conversely, B3GNT1, NOSTRIN and CADPS followed a reverse trend with down-regulation associated with poor outcome (Figures 1 and 2H), thus suggesting a tumour suppressor role. The gene discussed is NOSTRIN; the disease is neoplasm.